参考文献/References:
[1]KURODA S, HOUKIN K. Moyamoya disease: current concepts and future perspectives[J]. Lancet Neurol, 2008, 7(11): 1056-66.
[2]IHARA M, YAMAMOTO Y, HATTORI Y, et al. Moyamoya disease: diagnosis and interventions[J]. Lancet Neurol, 2022, 21(8): 747-758.
[3]El NAAMANI K, HUNT A, JAIN P, et al. The rate and predictors of 30-day readmission in patients treated for unruptured cerebral aneurysms: a large single-center study[J]. Neurosurgery, 2023, 93(6): 1415-1424.
[4]SPENCER RJ, ST GEORGE EJ. Unruptured untreated intracranial aneurysms: a retrospective analysis of outcomes of 445 aneurysms managed conservatively[J]. Br J Neurosurg, 2023, 37(6): 1643-1651.
[5]YANG Y, WANG B, GE X, et al. Natural course of ruptured but untreated intracranial aneurysms: a multicenter 2-year follow-up study[J]. Stroke, 2023, 54(8): 2087-2095.
[6]VLAK MH, ALGRA A, BRANDENBURG R, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis[J]. Lancet Neurol, 2011, 10(7): 626-36.
[7]TOMINARI S, MORITA A, ISHIBASHI T, et al. Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients[J]. Ann Neurol, 2015, 77(6): 1050-1059.
[8]BACKES D, RINKEL GJE, Greving JP, et al. ELAPSS score for prediction of risk of growth of unruptured intracranial aneurysms[J]. Neurology, 2017, 88(17): 1600-1606.
[9]SONG TT, LI YT, SONG M, et al. Establishment and validation of risk prediction scoring model for pulmonary infection in cerebral hemorrhage patients undergoing surgery[J]. Chin J Infect Control, 2021, 20(4): 299-303.宋甜田,李亚婷,宋 明,等. 脑出血手术患者肺部感染风险预测评分模型的构建与验证[J]中国感染控制杂志,2021,20(4):299-303.
[10]YANG RM, HAO FB, ZHAO B, et al. Natural course and risk factorsof moyamoya disease with unruptured intracranial aneurysm[J]. Front Neurol, 2023, 14: 1115909.
[11]KIM JH, KWON TH, KIM JH, et al. Intracranial aneurysms in adult moyamoya disease[J]. World Neurosurg, 2018, 109: e175-e182.
[12]GENG JW, ZHAI XD, JI Z, et al. Chinese guidelines for diagnosis and treatment of unruptured intracranial aneurysm 2021[J]. Chin J Cerebrovasc Dis, 2021, 18(9): 634-664.耿介文,翟晓东,吉 喆,等. 中国颅内未破裂动脉瘤诊疗指南2021[J]. 中国脑血管病杂志,2021,18(9):634-664.
[13]YANG H, ZHANG L, WANG M, et al. Clinical features of and risk factors for intracranial aneurysms associated with moyamoya disease[J]. Int J Stroke, 2021, 16(5): 542-550.
[14]ZHANG H, LU W, LIANG J, et al. Risk factors of rupture and mortality for intracranial aneurysms associated with moyamoya disease: a multicenter retrospective study[J]. Neurol Sci, 2024, 45(5): 2137-2147.
[15]CHO WS, CHUNG YS, KIM JE, et al. The natural clinical course of hemodynamically stable adult moyamoya disease[J]. J Neurosurg, 2015, 122(1): 82-89.
[16]MYEONG HS, KIM K, LEE SH, et al. Clinical significance of intracranial aneurysms in adult moyamoya disease[J]. World Neurosurg, 2022, 164: e1034-e1042.
[17]CUI X, WANG L, ZHAO Y, et al. Risk factors and location of intracranial aneurysm rupture in a consecutive Chinese han population[J]. World Neurosurg, 2024, 181: e214-e221.
相似文献/References:
[1]李 琴 袁辉胜.高压氧治疗抢救烟雾病合并一氧化碳中毒1例[J].中国临床神经外科杂志,2016,(07):441.[doi:10.13798/j.issn.1009-153X.2016.07.019]
[2]张登文 邓剑平 张 涛 陈 虎 赵振伟.颞浅动脉-颞浅筋膜-脑贴敷术治疗烟雾病疗效观察[J].中国临床神经外科杂志,2015,(06):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
ZHANG Deng-wen,DENG Jian-ping,ZHANG Tao,et al.Curative effect of encephalo-superficial temporal artery-superficial temporal fascia flap-synangiosis on Moyamoya disease (report of 31 cases)[J].,2015,(06):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
[3]刘锡禹 张正善 赵 峰 韩 聪 李 斌 段 炼.烟雾病合并后循环病变致继发枕叶梗死的相关危险因素分析[J].中国临床神经外科杂志,2015,(07):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
LIU Xi-yu,ZHANG Zheng-shan,ZHAO Feng,et al.Analysis of the risk factors related to occipital lobe infarction induced by Moyamoya disease complicated with posterior circulation lesions[J].,2015,(06):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
[4]黄 坦 黄书岚 陈谦学.颞浅动脉-大脑中动脉搭桥术治疗成人烟雾病[J].中国临床神经外科杂志,2015,(05):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
HUANG Tan,HUANG Shu-lan,CHEN Qian-xue..Treatment of Moyamoya disease with superficial temporal artery-middle cerebral artery bypass in adults[J].,2015,(06):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
[5]李 舜 唐晓平 文 军 罗仁国 张 柳 段军伟 彭 华 赵 龙.成人出血型烟雾病合并颅内动脉瘤的诊治及预后分析[J].中国临床神经外科杂志,2017,(04):213.[doi:10.13798/j.issn.1009-153X.2017.04.002]
LI Shun,TANG Xiao-ping,WEN Jun,et al.Diagnosis, treatment and prognosis of intracranial aneurysms in adults with hemorrhagic moyamoya disease[J].,2017,(06):213.[doi:10.13798/j.issn.1009-153X.2017.04.002]
[6]马廉亭.建议把“烟雾病”诊断还原为“脑基底异常血管网”症[J].中国临床神经外科杂志,2017,(07):449.[doi:10.13798/j.issn.1009-153X.2017.07.001]
[7]陈姣红 刘东媛 张红波 李明昌 熊晓星 陈谦学.成人出血型烟雾病围手术期护理观察[J].中国临床神经外科杂志,2018,(06):437.[doi:10.13798/j.issn.1009-153X.2018.06.020]
[8]杨允东 李永强.多普勒超声血流动力学监测在烟雾病STA-MCA吻合术中的应用[J].中国临床神经外科杂志,2018,(07):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
YANG Yun-dong,LI Yong-qiang..Change in the STA hymodynamics monitored by color Doppler ultrasound before and after STA-MCA anastomosis in patients with Moyamoya disease[J].,2018,(06):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
[9]欧阳光 黄书岚.烟雾病的现况及研究进展[J].中国临床神经外科杂志,2018,(08):564.[doi:doi:10.13798/j.issn.1009-153X.2018.08.020]
[10]黄彩菲,刘雅静,张红波,等.烟雾病血运重建术中配合及护理[J].中国临床神经外科杂志,2018,(10):692.[doi:10.13798/j.issn.1009-153X.2018.10.018]
[11]张华建,万蕾,罗先武,等.基于自我效能理论的有氧运动处方在脑底异常血管网症中的应用[J].中国临床神经外科杂志,2024,29(06):327.[doi:10.13798/j.issn.1009-153X.2024.06.002]
ZHANG Hua-jian,WAN Lei,LUO Xian-wu,et al.Application of aerobic exercise prescription based on self-efficacy theory in patients with moyamoya disease[J].,2024,29(06):327.[doi:10.13798/j.issn.1009-153X.2024.06.002]
[12]吴明洪,徐海涛,黄书岚.脑底异常血管网症血流重建术后并发脑高灌注综合征的危险因素[J].中国临床神经外科杂志,2024,29(08):495.[doi:10.13798/j.issn.1009-153X.2024.08.012]
WU Ming-hong,XU Hai-tao,HUANG Shu-lan.Risk factors for cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease[J].,2024,29(06):495.[doi:10.13798/j.issn.1009-153X.2024.08.012]